New York, Jan 5, 2026, 21:41 EST — Market closed
- NuScale Power shares closed up about 15% as nuclear-linked stocks rallied ahead of a U.S. House hearing on licensing and deployment.
- Trading volume topped 62 million shares, well above its recent average, extending a sharp start to 2026.
- Investors are watching for policy signals on Jan. 7 — and for any follow-on equity raise after NuScale expanded its authorized share count in December.
NuScale Power Corp shares jumped on Monday, with the small modular reactor developer closing up about 15% at $18.78. The move capped a second straight session of double-digit gains for the stock.
The rally matters because NuScale and its peers live and die on regulation and capital. Any hint that Washington wants faster licensing — the process regulators use to clear a reactor design and approve a plant site — can reset sentiment quickly in a sector that remains years from broad commercial deployment.
Traders pointed to a House Energy and Commerce subcommittee hearing on Wednesday that will focus on nuclear licensing and deployment under recently enacted laws and administration policies, according to the committee’s weekly schedule and the congressional calendar. The hearing is set for 10:15 a.m. ET.
NuScale was not alone. Oklo rose about 15% and Nano Nuclear Energy gained about 12%, while nuclear-services supplier BWX Technologies also advanced, as investors rotated into nuclear-linked names.
NuScale is developing small modular reactors, a smaller, factory-built take on nuclear plants that proponents say can be deployed in more places and scaled in modules. The company has pitched its NuScale Power Module as an NRC-approved design and a platform aimed at utilities and large industrial buyers.
Chief Executive John Hopkins has framed the demand backdrop as a tailwind for the technology. “Demand for reliable, always-on electricity is increasing,” Hopkins said on the company’s Nov. 6 earnings call. NuScale Power
Momentum traders were active on Monday. Volume reached 62.6 million shares, about 157% above NuScale’s three-month average of 24.3 million, a Nasdaq report said, and the stock is up more than 30% just two sessions into the year.
But the surge comes with a familiar overhang: dilution. NuScale disclosed in a December 8-K that shareholders approved doubling authorized Class A shares to 662 million, giving the company more room to issue stock — a standard financing tool for cash-burning developers, but one that can pressure existing holders.
With the market closed, investors are likely to watch whether the stock can hold Monday’s gains near the $19 area and how it trades around the $20 round number, where momentum often meets profit-taking. Any fresh filing, capital-raising move or regulatory update would also be in focus after the sharp two-day run.
The next clear catalyst is Wednesday’s House hearing at 10:15 a.m. ET, which could shape expectations for how quickly new nuclear projects move through licensing and into deployment.
